Seroprevalence of Dengue and Hepatitis B infections among young adults attending a secondary health care facility at Olabisi Onabanjo University, Ogun State, Nigeria

Hafeez A. Adekola(1), Georgia C. Agu(2), Festus A. Odeyemi(3), Haneefat O. Egberongbe(4), Ismail B. Onajobi(5), Wahab A. Kareem(6), Oyesanya O. Adejonwo(7),


(1) Olabisi Onabanjo University, Ogun State
(2) Olabisi Onabanjo University, Ogun State
(3) Olabisi Onabanjo University, Ogun State
(4) Olabisi Onabanjo University, Ogun State
(5) Olabisi Onabanjo University, Ogun State
(6) Olabisi Onabanjo University, Ogun State
(7) Olabisi Onabanjo University, Ogun State
Corresponding Author

Abstract


Hepatitis B and Dengue virus infections carry significant public health implications due to their potential to cause illness and death. This study focused on examining the prevalence of these infections among young adults seeking care at a secondary health facility at Olabisi Onabanjo University. Ninety samples obtained from study participants underwent screening using Enzyme-linked Immunosorbent Assay (ELISA) for both HBsAg and Dengue IgM. The participants, predominantly female, were aged between 15 and 30 years. The analysis revealed a 13.3% prevalence of Dengue IgM, a 4.5% prevalence of HBsAg, and a 4.4% prevalence for both infections. Regarding age distribution, the highest prevalence occurred among participants aged 15-20 years for both single infections and the co-occurrence of Hepatitis B and Dengue viral infections. Examining gender distribution, female participants exhibited higher seropositivity across all infection categories. Although not statistically significant, these findings lay the groundwork for a comprehensive surveillance study on the Hepatitis B and Dengue viral infections in young adults. This study provides valuable insights into the prevalence patterns of Hepatitis B and Dengue virus, offering a basis for further research and public health interventions in this population.


Keywords


Dengue, Hepatitis B, seroprevalence, young adults, Nigeria

References


Abesig J, Chen Y, Wang H, Sompo FM, & Wu IXY (2020). Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLOS ONE, 15(6), e0234348. https://doi.org/10.1371/journal.pone.0234348

Blessmann J, Winkelmann Y, Keoviengkhone L, Sopraseuth V, Kann S, Hansen J, El Halas H, Emmerich P, Schmidt-Chanasit J, Schmitz H, Mika A, & Deschermeier C (2020). Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People’s Democratic Republic). PLOS ONE, 15(3), e0230337. https://doi.org/10.1371/journal.pone.0230337

Dehghani R & Kassiri H (2021). A Review on Epidemiology of Dengue Viral Infection as an Emerging Disease. Research Journal of Pharmacy and Technology, 2296–2301. https://doi.org/10.52711/0974-360X.2021.00406

Djasrabe AK, Tietcheu Galani BR, Ali MM, Yandai FH, Nadlaou B, Habkreo M, & Njintang NY (2022). Serological Evidence of Hepatitis B and E and Dengue Coinfection in Chadian Patients and Impact on Lipidemia Profile. International Journal of Hepatology, 2022, 1–12. https://doi.org/10.1155/2022/8373061

Egbe KA, Ike A, & Egbe F (2023). Knowledge and burden of hepatitis B virus in Nasarawa State, Nigeria. Scientific African, 22, e01938. https://doi.org/10.1016/j.sciaf.2023.e01938

Emeribe AU, Abdullahi IN, Isong IK, Emeribe AO, Nwofe JO, Shuaib BI, Gwarzo AM, Usman Y, Sadi M, Umeozuru CM, Dangana A, Egenti BN, Mallam MAB, Emelonye AU, Aminu MS, Yahaya H, & Oyewusi, S. (2021). Dengue Virus is Hyperendemic in Nigeria from 2009 to 2020: A Contemporary Systematic Review. Infection & Chemotherapy, 53(2), 284. https://doi.org/10.3947/ic.2020.0142

Erhabor O, Mohammad SY, Bello L, Onuigwe FU, Abdulrahman Y, Zama I, Buhari H, Bagudo A, Ibrahim K, Ahmed M, Udomah FP, Adias TC, Erhabor T, & Okara GC (2020). Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria. Human Antibodies, 28(3), 233–243. https://doi.org/10.3233/HAB-200412

Ezea MC, Chukwuma OG, Igwe JO, Abone HO, Moses IB, Ibezim CN, & Esimone CO (2021a). Dengue in co-infection with Hepatitis B virus in Enugu, Eastern Nigeria: Seroprevalence, impacts and risk of increasing transmission. World Journal of Biological and Pharmaceutical Research, 1(2), 040–049. https://doi.org/10.53346/wjbpr.2021.1.2.0132

Ezea MC, Chukwuma OG, Igwe JO, Abone HO, Moses IB, Ibezim CN, & Esimone CO (2021b). Dengue in co-infection with Hepatitis B virus in Enugu, Eastern Nigeria: Seroprevalence, impacts and risk of increasing transmission. World Journal of Biological and Pharmaceutical Research, 1(2), 040–049. https://doi.org/10.53346/wjbpr.2021.1.2.0132

Ferrari M, Zevini A, Palermo E, Muscolini M, Alexandridi M, Etna MP, Coccia EM, Fernandez-Sesma A, Coyne C, Zhang DD, Marques ETA, Olagnier D, & Hiscott J (2020). Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication. Journal of Virology, 94(24). https://doi.org/10.1128/JVI.01551-20

Gebremeskel T, Beshah T, Tesfaye M, Beletew B, Mengesha A, & Getie A (2020). Assessment of Knowledge and Practice on Hepatitis B Infection Prevention and Associated Factors among Health Science Students in Woldia University, Northeast Ethiopia. Advances in Preventive Medicine, 2020, 1–6. https://doi.org/10.1155/2020/9421964

Ikegbunam MN, Onochie-Igbinedion ITO, Ekpunobi NF, Harrison A, Emmanuel E, Ushie SN, Adiukwu MU, & Esimone CO (2022). Comparison of Four Diagnostic Tests Methods for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies. Journal of Biosciences and Medicines, 10(05), 179–190. https://doi.org/10.4236/jbm.2022.105016

Majumdar A & Jana PK (2023). Emerging viral diseases. In Viral Infections and Antiviral Therapies (pp. 25–37). Elsevier. https://doi.org/10.1016/B978-0-323-91814-5.00024-6

Omatola CA, Onoja BA, & Agama J. (2020). Detection of Hepatitis B Surface Antigen among Febrile Patients in Ankpa, Kogi State, Nigeria. Journal of Tropical Medicine, 2020, 1–6. https://doi.org/10.1155/2020/5136785

Osuji A, Agbakoba N, Ifeanyichukwu M, Abdullahi I, Ezeanya-Bapka C, & Duru G (2020). Hepatitis B Virus Serological Profile and Associated Risk Factors in Surface Antigen Negative Blood Donors in Nigeria. Microbes and Infectious Diseases, 2(3), 440–450. https://doi.org/10.21608/mid.2020.33141.1025

Prajapati R, Mehta R, Kabrawala M, Nandwani S, Patel N, Sethia M, Magnani K, Tandel R, & Kumar A (2023). Dengue hepatitis: Incidence, spectrum and outcome. Indian Journal of Gastroenterology, 42(3), 355–360. https://doi.org/10.1007/s12664-023-01405-0

Raheem T, Orukpe-Moses M, Akindele S, Wahab M, Ojerinola O, Akande D, Ochacha IA, & Aniedobe M (2021). Age, Gender Pattern and Liver Function Markers in Hepatitis B and C Seropositive Participants Attending a Health Facility in Yaba-Lagos, Nigeria. Journal of Biosciences and Medicines, 09(07), 44–58. https://doi.org/10.4236/jbm.2021.97007

Shi Y & Zheng M (2020). Hepatitis B virus persistence and reactivation. BMJ, m2200. https://doi.org/10.1136/bmj.m2200

Yang X, Quam MBM, Zhang T, & Sang S (2021). Global burden for dengue and the evolving pattern in the past 30 years. Journal of Travel Medicine, 28(8). https://doi.org/10.1093/jtm/taab146


Full Text: PDF

Article Metrics

Abstract View : 57 times
PDF Download : 20 times

DOI: 10.57046/DOTR8940

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Proceedings of the Nigerian Academy of Science

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.